This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 M Messina , C Nagata & AH Wu (2006) Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55, 1–12.
2 MJ Messina (2003) Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr Rev 61, 117–131.
5 AW Hsing , L Tsao & SS Devesa (2000) International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85, 60–67.
6 H Shimizu , RK Ross , L Bernstein , R Yatani , BE Henderson & TM Mack (1991) Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63, 963–966.
7 LS Cook , M Goldoft , SM Schwartz & NS Weiss (1999) Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 161, 152–155.
8 HG Sim & CWS Cheng (2005) Changing demography of prostate cancer in Asia. Eur J Cancer 41, 834–845.
9 L Yan & EL Spitznagel (2005) Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 117, 667–669.
10 BJ Trock , L Hilakivi-Clarke & R Clarke (2006) Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98, 459–471.
12 AH Wu , P Wan , J Hankin , CC Tseng , MC Yu & MC Pike (2002) Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23, 1491–1496.
15 M Messina , W McCaskill-Stevens & JW Lampe (2006) Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst 98, 1275–1284.
16 GF Maskarinec , AE Williams & L Carlin (2003) Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev 12, 165–169.
18 C Atkinson , RML Warren , E Sala , M Dowsett , AM Dunning , CS Healey , S Runswick , NE Day & SA Bingham (2004) Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial ISRCTN42940165. Breast Cancer Res 6, R170–R179.
20 RS Rosenberg Zand , DJ Jenkins & EP Diamandis (2002) Flavonoids and steroid hormone-dependent cancers. J Chromatogr B Analyt Technol Biomed Life Sci 777, 219–232.
24 SM Heinonen , A Hoikkala , K Wahala & H Adlercreutz (2003) Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton. J Steroid Biochem Mol Biol 87, 285–299.
25 SM Heinonen , K Wahala , KH Liukkonen , AM Aura , K Poutanen & H Adlercreutz (2004) Studies of the in vitro intestinal metabolism of isoflavones aid in the identification of their urinary metabolites. J Agric Food Chem 52, 2640–2646.
26 CE Rufer , H Glatt & SE Kulling (2006) Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography–mass spectrometry and high-performance liquid chromatography–mass spectrometry. Drug Metab Dispos 34, 51–60.
30 H Akaza , N Miyanaga , N Takashima , S Naito , Y Hirao , T Tsukamoto , T Fujioka , M Mori , WJ Kim , JM Song & AJ Pantuck (2004) Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34, 86–89.
32 CL Frankenfeld , A McTiernan , SS Tworoger , C Atkinson , WK Thomas , FZ Stanczyk , SM Marcovina , DS Weigle , NS Weiss , VL Holt , SM Schwartz & JW Lampe (2004) Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes. J Steroid Biochem Mol Biol 88, 399–408.
35 MD Niculescu , EA Pop , LM Fischer & SH Zeisel (2007) Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. J Nutr Biochem 18, 380–390.
36 F Li , MAJ Hullar & JW Lampe (2007) Optimization of terminal restriction fragment polymorphism (TRFLP) analysis of human gut microbiota. J Microbiol Methods 68, 303–311.
37 K Dettmer , PA Aronov & BD Hammock (2007) Mass spectrometry-based metabolomics. Mass Spectrom Rev 26, 51–78.
38 J Kaput & RL Rodriguez (2004) Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics 16, 166–177.
39 M Hedelin , KA Balter , ET Chang , R Bellocco , A Klint , JE Johansson , F Wiklund , C Thellenberg-Karlsson , HO Adami & H Gronberg (2006) Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. Prostate 66, 1512–1520.
41 DR Rhodes , JJ Yu , K Shanker , N Deshpande , R Varambally , D Ghosh , T Barrette , A Pandey & AM Chinnaiyan (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A 101, 9309–9314.
42 NS Azad , N Rasool , CM Annunziata , L Minasian , G Whiteley & EC Kohn (2006) Proteomics in clinical trials and practice – present uses and future promise. Mol Cell Proteomics 5, 1819–1829.
44 A Calvo , O Gonzalez-Moreno , CY Yoon , JI Huh , K Desai , QT Nguyen & JE Green (2005) Prostate cancer and the genomic revolution: advances using microarray analyses. Mutat Res 576, 66–79.
45 KW Jordan & LL Cheng (2007) NMR-based metabolomics approach to target biomarkers for human prostate cancer. Expert Rev Proteomics 4, 389–400.
47 WB Murrill , NM Brown , JX Zhang , PA Manzolillo , S Barnes & CA Lamartiniere (1996) Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17, 1451–1457.
49 L Hilakivi-Clarke , I Onojafe , M Raygada , E Cho , T Skaar , I Russo & R Clarke (1999) Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br J Cancer 80, 1682–1688.
50 CA Lamartiniere (2002) Timing of exposure and mammary cancer risk. J Mammary Gland Biol Neoplasia 7, 67–76.
51 A Cabanes , M Wang , S Olivo , S DeAssis , JA Gustafsson , G Khan & L Hilakivi-Clarke (2004) Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 25, 741–748, .
57 YH Ju , KF Allred , CD Allred & WG Helferich (2006) Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. Carcinogenesis 27, 1292–1299.
58 JH Yang , H Nakagawa , K Tsuta & A Tsubura (2000) Influence of perinatal genistein exposure on the development of MNU-induced mammary carcinoma in female Sprague–Dawley rats. Cancer Lett 149, 171–179.
59 Y Su , RR Eason , Y Geng , SR Till , TM Badger & RCM Simmen (2007) In utero exposure to maternal diets containing soy protein isolate, but not genistein alone, protects young adult rat offspring from NMU-induced mammary tumorigenesis. Carcinogenesis 28, 1046–1051.
60 E Padilla-Banks , WN Jefferson & RR Newbold (2006) Neonatal exposure to the phytoestrogen genistein alters mammary gland growth and developmental programming of hormone receptor levels. Endocrinology 147, 4871–4882.
61 DC Dolinoy , JR Weidman , RA Waterland & RL Jirtle (2006) Maternal genistein alters coat color and protects A(vy) mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114, 567–572.
64 CA Lamartiniere , J Wang , M Smith-Johnson & IE Eltoum (2002) Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol Sci 65, 228–238.
65 YH Ju , J Fultz , KF Allred , DR Doerge & WG Helferich (2006) Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis 27, 856–863.
66 CD Allred , KF Allred , YH Ju , TS Goeppinger , DR Doerge & WG Helferich (2004) Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 25, 1649–1657.
67 T Ohta , S Nakatsugi , K Watanabe , T Kawamori , F Ishikawa , M Morotomi , S Sugie , T Toda , T Sugimura & K Wakabayashi (2000) Inhibitory effects of bifidobacterium-fermented soy milk on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinogenesis, with a partial contribution of its component isoflavones. Carcinogenesis 21, 937–941.
68 C Wang & MS Kurzer (1998) Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutr Cancer 31, 90–100.
69 JC Le Bail , Y Champavier , AJ Chulia & G Habrioux (2000) Effects of phytoestrogens on aromatase, 3 beta and 17 beta-hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci 66, 1281–1291.
71 SJ Hong , SI Kim , SM Kwon , JR Lee & BC Chung (2002) Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Med J 43, 236–241.
72 A Rannikko , A Petas , S Rannikko & H Adlercreutz (2006) Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation. Prostate 66, 82–87.
73 MS Morton , PS Chan , C Cheng , N Blacklock , A Matos-Ferreira , L Abranches-Monteiro , R Correia , S Lloyd & K Griffiths (1997) Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate 32, 122–128.
75 J Maubach , HT Depypere , J Goeman , J Van Der Eycken , A Heyerick , ME Bracke , P Blondeel & D De Keukeleire (2004) Distribution of soy-derived phytoestrogens in human breast tissue and biological fluids. Obstet Gynecol 103, 892–898.
76 ZC Dang , V Audinot , SE Papapoulos , JA Boutin & CW Lowik (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 278, 962–967.
81 R Turner , T Baron , S Wolffram , AM Minihane , A Cassidy , G Rimbach & PD Weinberg (2004) Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radic Res 38, 209–216.
82 G Rimbach , PD Weinberg , S de Pascual-Teresa , MG Alonso , BA Ewins , R Turner , AM Minihane , N Botting , B Fairley , S Matsugo , Y Uchida & A Cassidy (2004) Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function. Biochim Biophys Acta 1670, 229–237.
83 F Pizzagalli , Z Varga , RD Huber , G Folkers , PJ Meier & MV St-Pierre (2003) Identification of steroid sulfate transport processes in the human mammary gland. J Clin Endocrinol Metab 88, 3902–3912.
85 MF McCarty (2006) Isoflavones made simple – genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med Hypotheses 66, 1093–1114.
86 FH Sarkar & YW Li (2004) Cell signaling pathways altered by natural chemopreventive agents. Mutat Res 555, 53–64.
87 K Pettersson & JA Gustafsson (2001) Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 63, 165–192.
88 MK Lindberg , S Moverare , S Skrtic , H Gao , K Dahlman-Wright , JA Gustafsson & C Ohlsson (2003) Estrogen receptor (ER)-beta reduces ER alpha-regulated gene transcription, supporting a ‘Ying Yang’ relationship between ER alpha and ER beta in mice. Mol Endocrinol 17, 203–208.
89 MM Liu , C Albanese , CM Anderson , K Hilty , P Webb , RM Uht , RH Price , RG Pestell & PJ Kushner (2002) Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 277, 24353–24360.
92 KA Power & LU Thompson (2003) Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation. Breast Cancer Res Treat 81, 209–221.
94 D Gallo , S Giacomelli , F Cantelmo , GF Zannoni , G Ferrandina , E Fruscella , A Riva , P Morazzoni , E Bombardelli , S Mancuso & G Scambia (2001) Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy. Breast Cancer Res Treat 69, 153–164.
95 A Dalu , BS Blaydes , CW Bryant , JR Latendresse , CC Weis & K Barry Delclos (2002) Estrogen receptor expression in the prostate of rats treated with dietary genistein. J Chromatogr B Analyt Technol Biomed Life Sci 777, 249–260.
96 WA Fritz , J Wang , IE Eltoum & CA Lamartiniere (2002) Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endocrinol 186, 89–99.
97 J Wang , IE Eltoum & CA Lamartiniere (2007) Genistein chemoprevention of prostate cancer in TRAMP mice. J Carcinog 6, 3.
98 G Kuiper , B Carlsson , K Grandien , E Enmark , J Haggblad , S Nilsson & JA Gustafsson (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863–870.
99 GG Kuiper , JG Lemmen , B Carlsson , JC Corton , SH Safe , PT van der Saag , B van der Burg & JA Gustafsson (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252–4263.
100 J Matthews & JA Gustafsson (2003) Estrogen signaling: a subtle balance between ERalpha and ERbeta. Mol Interv 3, 281–292.
101 ACW Pike , AM Brzozowski & RE Hubbard (2000) A structural biologist's view of the oestrogen receptor. J Steroid Biochem Mol Biol 74, 261–268.
102 K Morito , T Hirose , J Kinjo , T Hirakawa , M Okawa , T Nohara , S Ogawa , S Inoue , M Muramatsu & Y Masamune (2001) Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 24, 351–356.
103 D Kostelac , G Rechkemmer & K Briviba (2003) Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem 51, 7632–7635.
105 M Maggiolini , A Vivacqua , A Carpino , D Bonofiglio , G Fasanella , M Salerno , D Picard & S Ando (2002) The mutant androgen receptor T877A mediates the proliferative but not the cytotoxic dose-dependent effects of genistein and quercetin on human LNCaP prostate cancer cells. Mol Pharmacol 62, 1027–1035.
106 L Fioravanti , V Cappelletti , P Miodini , E Ronchi , M Brivio & G Di Fronzo (1998) Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett 130, 143–152.
107 CE Wood , TC Register , AA Franke , MS Anthony & JM Cline (2006) Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res 66, 1241–1249.
108 TT Wang , N Sathyamoorthy & JM Phang (1996) Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17, 271–275.
109 N Sathyamoorthy & TT Wang (1997) Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur J Cancer 33, 2384–2389.
110 DF Hargreaves , CS Potten , C Harding , LE Shaw , MS Morton , SA Roberts , A Howell & NJ Bundred (1999) Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 84, 4017–4024.
113 J Bektic , AP Berger , K Pfeil , G Dobler , G Bartsch & H Klocker (2004) Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta. Eur Urol 45, 245–251, .
114 S Gao , GZ Liu & ZX Wang (2004) Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells. Prostate 59, 214–225.
116 JN Davis , O Kucuk & FH Sarkar (2002) Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells. Mol Carcinog 34, 91–101.
118 KS Weber , KDR Setchell , DM Stocco & ED Lephart (2001) Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5 alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague–Dawley rats. J Endocrinol 170, 591–599.
119 JR Zhou , LY Yu , Y Zhong , RL Nassr , AA Franke , SM Gaston & GL Blackburn (2002) Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components. Prostate 53, 143–153.
120 TD Lund , DJ Munson , ME Haldy , KDR Setchell , ED Lephart & RJ Handa (2004) Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod 70, 1188–1195.
122 S Makela , M Poutanen , J Lehtimaki , ML Kostian , R Santti & R Vihko (1995) Estrogen-specific 17-beta-hydroxysteroid oxidoreductase type-1 (Ec-184.108.40.206) as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med 208, 51–59.
123 SA Whitehead & S Rice (2006) Endocrine-disrupting chemicals as modulators of sex steroid synthesis. Best Pract Res Clin Endocrinol Metab 20, 45–61.
124 YC Kao , C Zhou , M Sherman , CA Laughton & S Chen (1998) Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environ Health Perspect 106, 85–92.
125 S Makela , M Poutanen , ML Kostian , N Lehtimaki , L Strauss , R Santti & R Vihko (1998) Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc Soc Exp Biol Med 217, 310–316.
126 BA Evans , K Griffiths & MS Morton (1995) Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147, 295–302.
127 CJ Kirk , RM Harris , DM Wood , RH Waring & PJ Hughes (2001) Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens? Biochem Soc Trans 29, 209–216.
128 CK Wong & WM Keung (1997) Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 220.127.116.11). Biochem Biophys Res Commun 233, 579–583.
129 RM Harris , DM Wood , L Bottomley , S Blagg , K Owen , PJ Hughes , RH Waring & CJ Kirk (2004) Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. J Clin Endocrinol Metab 89, 1779–1787.
130 NB Kumar , A Cantor , K Allen , D Riccardi & CE Cox (2002) The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer 94, 1166–1174.
133 Y Mousavi & H Adlercreutz (1993) Genistein is an effective stimulator of sex-hormone binding globulin production in hepatocarcinoma human liver-cancer cells and suppresses proliferation of these cells in culture. Steroids 58, 301–304.
134 CE Wood , TC Register & JM Cline (2007) Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys. Carcinogenesis 28, 801–808.
135 AM Duncan , KE Underhill , X Xu , J Lavalleur , WR Phipps & MS Kurzer (1999) Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 84, 3479–3484.
140 E Horia & BA Watkins (2007) Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE(2) and invasiveness in MDA-MB-231 breast cancer cells. Carcinogenesis 28, 809–815.
141 E Elstner , C Muller , K Koshizuka , EA Williamson , D Park , H Asou , P Shintaku , JW Said , D Heber & HP Koeffler (1998) Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci U S A 95, 8806–8811.
142 E Mueller , P Sarraf , P Tontonoz , RM Evans , KJ Martin , M Zhang , C Fletcher , S Singer & BM Spiegelman (1998) Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell 1, 465–470.
143 E Mueller , M Smith , P Sarraf , T Kroll , A Aiyer , DS Kaufman , W Oh , G Demetri , WD Figg , XP Zhou , C Eng , BM Spiegelman & PW Kantoff (2000) Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc Natl Acad Sci U S A 97, 10990–10995.
144 S Theocharis , A Margeli , P Vielh & G Kouraklis (2004) Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators. Cancer Treat Rev 30, 545–554.
145 T Suzuki , S Hayashi , Y Miki , Y Nakamura , T Moriya , A Sugawara , T Ishida , N Ohuchi & H Sasano (2006) Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. Endocr Relat Cancer 13, 233–250.
146 S Han & J Roman (2007) Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics? Anticancer Drugs 18, 237–244.
148 JC Shen , RD Klein , Q Wei , Y Guan , JH Contois , TT Wang , S Chang & SD Hursting (2000) Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells. Mol Carcinog 29, 92–102.
149 JN Davis , B Singh , M Bhuiyan & FH Sarkar (1998) Genistein-induced upregulation of p21(WAF1), downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer 32, 123–131.
150 AL Hewitt & KW Singletary (2003) Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model. Cancer Lett 192, 133–143.
152 RS Frey , J Li & KW Singletary (2001) Effects of genistein on cell proliferation and cell cycle arrest in nonneoplastic human mammary epithelial cells: involvement of Cdc2, p21(waf/cip1), p27(kip1), and Cdc25C expression. Biochem Pharmacol 61, 979–989.
153 RW King , PK Jackson & MW Kirschner (1994) Mitosis in transition. Cell 79, 563–571.
155 L Rice , VG Samedi , TA Medrano , CA Sweeney , HV Baker , A Stenstrom , J Furman & KT Shiverick (2002) Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts. Prostate 52, 201–212.
156 LH Touny & PP Banerjee (2006) Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein. Prostate 66, 1542–1555.
157 CH Liao , SL Pan , JH Guh & CM Teng (2004) Genistein inversely affects tubulin-binding agent-induced apoptosis in human breast cancer cells. Biochem Pharmacol 67, 2031–2038.
159 J Gautier , MJ Solomon , RN Booher , JF Bazan & MW Kirschner (1991) cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 67, 197–211.
160 Y Li , S Upadhyay , M Bhuiyan & FH Sarkar (1999) Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18, 3166–3172.
161 KA Waite , MR Sinden & C Eng (2005) Phytoestrogen exposure elevates PTEN levels. Hum Mol Genet 14, 1457–1463.
162 I Eto (2006) Nutritional and chemopreventive anti-cancer agents up-regulate expression of p27Kip1, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells. Cancer Cell Int 6, 20.
163 B Dave , RR Eason , SR Till , Y Geng , MC Velarde , TM Badger & RC Simmen (2005) The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 26, 1793–1803.
164 T Kobayashi , T Nakata & T Kuzumaki (2002) Effect of flavonoids on cell cycle progression in prostate cancer cells. Cancer Lett 176, 17–23.
165 A Kazi , KG Daniel , DM Smith , NB Kumar & QP Dou (2003) Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochem Pharmacol 66, 965–976.
167 DL Bemis , JL Capodice , M Desai , R Buttyan & AE Katz (2004) A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo. Clin Cancer Res 10, 5282–5292.
170 LH El Touny & PP Banerjee (2007) Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells. Biochem Biophys Res Commun 361, 169–175.
171 H Skogseth , E Larsson & J Halgunset (2006) The invasive behaviour of prostatic cancer cells is suppressed by inhibitors of tyrosine kinase. Apmis 114, 61–66.
172 JK Kumi-Diaka , M Hassanhi , K Merchant & V Horman (2006) Influence of genistein isoflavone on matrix metalloproteinase-2 expression in prostate cancer cells. J Med Food 9, 491–497.
176 G Peterson & S Barnes (1993) Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22, 335–345.
179 A Dalu , JF Haskell , L Coward & CA Lamartiniere (1998) Genistein, a component of soy, inhibits the expression of the EGF and ErbB2/Neu receptors in the rat dorsolateral prostate. Prostate 37, 36–43.
180 J Wang , IE Eltoum & CA Lamartiniere (2004) Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Mol Cell Endocrinol 219, 171–180.
181 NM Brown , J Wang , MS Cotroneo , YX Zhao & CA Lamartiniere (1998) Prepubertal genistein treatment modulates TGF-alpha, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol Cell Endocrinol 144, 149–165.
183 MS Cotroneo , J Wang , WA Fritz , IE Eltoum & CA Lamartiniere (2002) Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis 23, 1467–1474.
184 WF Chen & MS Wong (2004) Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J Clin Endocrinol Metab 89, 2351–2359.
185 HM Aukema & I Housini (2001) Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats. Kidney Int 59, 52–61.
186 C Nagata , H Shimizu , R Takami , M Hayashi , N Takeda & K Yasuda (2003) Dietary soy and fats in relation to serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 levels in premenopausal Japanese women. Nutr Cancer 45, 185–189.
188 A Vrieling , DW Voskuil , HB Bueno de Mesquita , R Kaaks , PA van Noord , L Keinan-Boker , CH van Gils & PH Peeters (2004) Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in The Netherlands. Cancer Causes Control 15, 787–796.
189 BH Arjmandi , DA Khalil , BJ Smith , EA Lucas , S Juma , ME Payton & RA Wild (2003) Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 88, 1048–1054.
190 JV Woodside , MJ Campbell , EE Denholm , L Newton , JW Honour , MS Morton , IS Young & AJ Leathem (2006) Short-term phytoestrogen supplementation alters insulin-like growth factor profile but not lipid or antioxidant status. J Nutr Biochem 17, 211–215.
191 KE Wangen , AM Duncan , BE Merz-Demlow , X Xu , R Marcus , WR Phipps & MS Kurzer (2000) Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 85, 3043–3048.
195 M Hussain , M Banerjee , FH Sarkar , Z Djuric , MN Pollak , D Doerge , J Fontana , S Chinni , J Davis , J Forman , DP Wood & O Kucuk (2003) Soy isoflavones in the treatment of prostate cancer. Nutr Cancer 47, 111–117.
196 S Jagadeesh , S Kyo & PP Banerjee (2006) Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res 66, 2107–2115.
197 LH El Touny & PP Banerjee (2007) Akt/GSK3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression towards a poorly differentiated phenotype. Carcinogenesis.
198 Y Li & FH Sarkar (2002) Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett 186, 157–164.
199 L Gong , Y Li , A Nedeljkovic-Kurepa & FH Sarkar (2003) Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 22, 4702–4709.
201 JN Davis , O Kucuk & FH Sarkar (1999) Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr Cancer 35, 167–174.
202 W Vanden Berghe , N Dijsselbloem , L Vermeulen , N Ndlovu , E Boone & G Haegeman (2006) Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-kappaB gene expression by soy isoflavones does not require estrogenic activity. Cancer Res 66, 4852–4862.
203 C Borras , J Gambini , MC Gomez-Cabrera , J Sastre , FV Pallardo , GE Mann & J Vina (2006) Genistein, a soy isoflavone, up-regulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NF kappa B. FASEB J 20, 2136.
204 XY Wang , EA Clubbs & JA Bomser (2006) Genistein modulates prostate epithelial cell proliferation via estrogen- and extracellular signal-regulated kinase-dependent pathways. J Nutr Biochem 17, 204–210.
205 EA Clubbs & JA Bomser (2007) Glycitein activates extracellular signal-regulated kinase via vascular endothelial growth factor receptor signaling in nontumorigenic (RWPE-1) prostate epithelial cells. J Nutr Biochem 18, 525–532.
206 D Thompson & DF Easton (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94, 1358–1365.
207 SJ Boulton (2006) Cellular functions of the BRCA tumour-suppressor proteins. Biochem Soc Trans 34, 633–645.
208 EM Rosen , S Fan , RG Pestell & ID Goldberg (2003) BRCA1 in hormone-responsive cancers. Trends Endocrinol Metab 14, 378–385.
209 S Fan , Q Meng , K Auborn , T Carter & EM Rosen (2006) BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer 94, 407–426.
211 CE Rufer & SE Kulling (2006) Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J Agric Food Chem 54, 2926–2931.
212 H Wei , L Wei , K Frenkel , R Bowen & S Barnes (1993) Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20, 1–12.
213 RP Patel , BJ Boersma , JH Crawford , N Hogg , M Kirk , B Kalyanaraman , DA Parks , S Barnes & V Darley-Usmar (2001) Antioxidant mechanisms of isoflavones in lipid systems: paradoxical effects of peroxyl radical scavenging. Free Radic Biol Med 31, 1570–1581.
214 M Raschke , IR Rowland , PJ Magee & BL Pool-Zobel (2006) Genistein protects prostate cells against hydrogen peroxide-induced DNA damage and induces expression of genes involved in the defence against oxidative stress. Carcinogenesis 27, 2322–2330.
215 RA DiSilvestro , J Goodman , E Dy & G Lavalle (2005) Soy isoflavone supplementation elevates erythrocyte superoxide dismutase, but not plasma ceruloplasmin in postmenopausal breast cancer survivors. Breast Cancer Res Treat 89, 251–255.
218 WX Peng , HD Li & HH Zhou (2003) Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers. Eur J Clin Pharmacol 59, 237–241.
219 C Steiner , WH Peters , EP Gallagher , P Magee , I Rowland & BL Pool-Zobel (2007) Genistein protects human mammary epithelial cells from benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide and 4-hydroxy-2-nonenal genotoxicity by modulating the glutathione/glutathione S-transferase system. Carcinogenesis 28, 738–748.
220 NR Bianco , LJ Chaplin & MM Montano (2005) Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage. Biochem J 385, 279–287.
221 H Farhan , K Wahala & HS Cross (2003) Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells. J Steroid Biochem Mol Biol 84, 423–429.
225 MA Lila & I Raskin (2005) Health-related interactions of phytochemicals. J Food Sci 70, R20–R27.
227 T Ueda , NR Mawji , N Bruchovsky & MD Sadar (2002) Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells. J Biol Chem 277, 38087–38094.
228 S Kato , Y Masuhiro , M Watanabe , Y Kobayashi , K Takeyama , H Endoh & J Yanagisawa (2000) Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways. Genes Cells 5, 593–601.
229 MF McCarty (2004) Targeting Multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy. Integr Cancer Ther 3, 349–380.
230 IHL Hamelers & PH Steenbergh (2003) Interactions between insulin-like growth factor estrogen and signaling pathways in human breast tumor cells. Endocr Relat Cancer 10, 331–345.
231 X Wang & MW Kilgore (2002) Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamina1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol 194, 123–133.
232 D Bonofiglio , S Gabriele , S Aquila , S Catalano , M Gentile , E Middea , F Giordano & S Ando (2005) Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells. Clin Cancer Res 11, 6139–6147.
233 K De Bosscher , W Vanden Berghe & G Haegeman (2006) Cross-talk between nuclear receptors and nuclear factor kappa B. Oncogene 25, 6868–6886.
234 KM Vasudevan , S Gurumurthy & VM Rangnekar (2004) Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol Cell Biol 24, 1007–1021.
235 S Terasaka , Y Aita , A Inoue , S Hayashi , M Nishigaki , K Aoyagi , H Sasaki , Y Wada-Kiyama , Y Sakuma , S Akaba , J Tanaka , H Sone , J Yonemoto , M Tanji & R Kiyama (2004) Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ Health Perspect 112, 773–781.
236 R Ise , D Han , Y Takahashi , S Terasaka , A Inoue , M Tanji & R Kiyama (2005) Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Lett 579, 1732–1740.
237 JG Moggs , J Ashby , H Tinwell , FL Lim , DJ Moore , I Kimber & G Orphanides (2004) The need to decide if all estrogens are intrinsically similar. Environ Health Perspect 112, 1137–1142.
238 JM Naciff , ML Jump , SM Torontali , GJ Carr , JP Tiesman , GJ Overmann & GP Daston (2002) Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol Sci 68, 184–199.
239 N Konstantakopoulos , KG Montgomery , N Chamberlain , MA Quinn , MS Baker , GE Rice , HM Georgiou & IG Campbell (2006) Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells. Mol Carcinog 45, 752–763.
240 JM Naciff & GP Daston (2004) Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity. Toxicol Pathol 32, 59–70.
241 T Shioda , J Chesnes , KR Coser , LH Zou , J Hur , KL Dean , C Sonnenschein , AM Soto & KJ Isselbacher (2006) Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc Natl Acad Sci U S A 103, 12033–12038.
242 T Buterin , C Koch & H Naegeli (2006) Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis 27, 1567–1578.
243 AR Thomsen , K Almstrup , JE Nielsen , IK Sorensen , OW Petersen , H Leffers & VM Breinholt (2006) Estrogenic effect of soy isoflavones on mammary gland morphogenesis and gene expression profile. Toxicol Sci 93, 357–368.
244 TP York , SR Plymate , PS Nelson , LJ Eaves , HD Webb & JL Ware (2005) cDNA microarray analysis identifies genes induced in common by peptide growth factors and androgen in human prostate epithelial cells. Mol Carcinog 44, 242–251.
245 L You & EJ Bartolucci (2004) Gene expression profiles in mammary gland of male rats treated with genistein and methoxychlor. Environ Toxicol Pharmacol 18, 161–172.
246 Y Takahashi , JA Lavigne , SD Hursting , GVR Chandramouli , SN Perkins , JC Barrett & TTY Wang (2004) Using DNA microarray analyses to elucidate the effects of genistein in androgen-responsive prostate cancer cells: identification of novel targets. Mol Carcinog 41, 108–119.
247 Y Takahashi , JA Lavigne , SD Hursting , GVR Chandramouli , SN Perkins , YS Kim & TTY Wang (2006) Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray. Mol Carcinog 45, 943–956.
248 Y Takahashi , SD Hursting , SN Perkins , TC Wang & TTY Wang (2006) Genistein affects androgen-responsive genes through both androgen- and estrogen-induced signaling pathways. Mol Carcinog 45, 18–25.
249 YW Li , MX Che , S Bhagat , KL Ellis , O Kucuk , DR Doerge , J Abrams , ML Cher & FH Sarkar (2004) Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia 6, 354–363.
250 K Suzuki , H Koike , H Matsui , Y Ono , M Hasumi , H Nakazato , H Okugi , Y Sekine , K Oki , K Ito , T Yamamoto , Y Fukabori , K Kurokawa & H Yamanaka (2002) Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int J Cancer 99, 846–852.
251 WF Chen , MH Huang , CH Tzang , M Yang & MS Wong (2003) Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochim Biophys Acta 1638, 187–196.
254 KS Solanky , NJ Bailey , BM Beckwith-Hall , S Bingham , A Davis , E Holmes , JK Nicholson & A Cassidy (2005) Biofluid H-1 NMR-based metabonomic techniques in nutrition research metabolic effects of dietary isoflavones in humans. J Nutr Biochem 16, 236–244.
255 KS Solanky , NJC Bailey , BM Beckwith-Hall , A Davis , S Bingham , E Holmes , JK Nicholson & A Cassidy (2003) Application of biofluid H-1 nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal Biochem 323, 197–204.
257 JR Fay , JA Crowell & L Kopelovich (2005) Targeting epigenetic regulatory mechanisms in cancer chemoprevention. Expert Opin Ther Targets 9, 315–328.
258 JE Leader , C Wang , M Fu & RG Pestell (2006) Epigenetic regulation of nuclear steroid receptors. Biochem Pharmacol 72, 1589–1596.
259 YP Yu , S Paranjpe , J Nelson , S Finkelstein , B Ren , D Kokkinakis , G Michalopoulos & JH Luo (2005) High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array. Carcinogenesis 26, 471–479.
261 MZ Fang , D Chen , Y Sun , Z Jin , JK Christman & CS Yang (2005) Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11, 7033–7041.
262 T Hong , T Nakagawa , WJ Pan , MY Kim , WL Kraus , T Ikehara , K Yasui , H Aihara , M Takebe , M Muramatsu & T Ito (2004) Isoflavones stimulate estrogen receptor-mediated core histone acetylation. Biochem Biophys Res Commun 317, 259–264.
263 TD Lund , DJ Munson , H Adlercreutz , RJ Handa & ED Lephart (2004) Androgen receptor expression in the rat prostate is down-regulated by dietary phytoestrogens. Reprod Biol Endocrinol 2, 5–10.
264 CK Wong & WM Keung (1999) Bovine adrenal 3beta-hydroxysteroid dehydrogenase (E.C. 1.1.1. 145)/5-ene-4-ene isomerase (E.C. 18.104.22.168): characterization and its inhibition by isoflavones. J Steroid Biochem Mol Biol 71, 191–202.
265 RA Hiipakka , HZ Zhang , W Dai , Q Dai & ST Liao (2002) Structure–activity relationships for inhibition of human 5 alpha-reductases by polyphenols. Biochem Pharmacol 63, 1165–1176.
266 H Adlercreutz , K Hockerstedt , C Bannwart , S Bloigu , E Hamalainen , T Fotsis & A Ollus (1987) Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 27, 1135–1144.
267 AM Pino , LE Valladares , MA Palma , AM Mancilla , M Yanez & C Albala (2000) Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Clin Endocrinol Metab 85, 2797–2800.
268 A Brzezinski , H Adlercreutz , R Shaoul , A Rosler , A Shmueli , V Tanos & JG Schenker (1997) Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 4, 89–94.
269 S Goodin , F Shen , WJ Shih , N Dave , MP Kane , P Medina , GH Lambert , J Aisner , M Gallo & RS DiPaola (2007) Clinical and biological activity of soy protein powder supplementation in healthy male volunteers. Cancer Epidemiol Biomarkers Prev 16, 829–833.
270 A Rannikko , A Petas , T Raivio , OA Janne , S Rannikko & H Adlercreutz (2006) The effects of short-term oral phytoestrogen supplementation on the hypothalamic–pituitary–testicular axis in prostate cancer patients. Prostate 66, 1086–1091.
271 ZM Shao , ML Alpaugh , JA Fontana & SH Barsky (1998) Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21(WAF1/CIP1) induction, G(2)/M arrest, and apoptosis. J Cell Biochem 69, 44–54.
275 EM Laurenzana , CC Weis , CW Bryant , R Newbold & KB Delclos (2002) Effect of dietary administration of genistein, nonylphenol or ethinyl estradiol on hepatic testosterone metabolism, cytochrome P-450 enzymes, and estrogen receptor alpha expression. Food Chem Toxicol 40, 53–63.
276 MB van Duursen , JT Sanderson , PC de Jong , M Kraaij & M van den Berg (2004) Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage. Toxicol Sci 81, 316–324.